Episyringaresinol 4'-O-β-D-glncopyranoside

SKU: orb1297633

Description

This small molecule, Episyringaresinol 4'-O-β-D-glucopyranoside, demonstrates anti-proliferative activity against human promyelocytic HL-60 cells by inducing G1 phase cell cycle arrest and apoptosis. Its mechanism suggests potential for further research in oncology, particularly in exploring natural product-derived chemotherapeutic agents through in vitro studies.

Key Properties

• CAS Number: 137038-13-2
• MW: 580.58
• Purity: 99.89% (May vary between batches)
• Formula: C₂₈H₃₆O₁₃
• SMILES: [H][C@@]12CO[C@@H](c3cc(OC)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c3)[C@]1([H])CO[C@H]2c1cc(OC)c(O)c(OC)c1
• Target: Others
• Solubility: DMSO:50 mg/mL (86.12 mM)

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

inhibit, Episyringaresinol 4' O β D glncopyranoside, Episyringaresinol 4'-O-b-D-glncopyranoside, Episyringaresinol 4'-O-beta-D-glncopyranoside, Episyringaresinol 4'OβDglncopyranoside, Episyringaresinol 4'-O-β-D-glncopyranoside, Inhibitor, (-)-Syringaresinol 4-O-β-D-glucopyranosi, Syringaresinol 4-O-b-D-glucopyranosi, Syringaresinol 4-O-beta-D-glucopyranosi, Syringaresinol 4-O-β-D-glucopyranosi

Compound Identifiers

PubChem CID

45482321